This is a phase III, multi-center international, single blind randomized controlled trial to
test the efficacy of pulsed intravenous (IV) methylprednisolone versus standard therapy on
top of maximal support in patients with Acute myocarditis (AM).
Phase:
Phase 3
Details
Lead Sponsor:
Niguarda Hospital
Collaborators:
Istituto Di Ricerche Farmacologiche Mario Negri Ministry of Health, Italy Regione Lombardia University of Milano Bicocca